| methylprednisolone sodium succinate / Generic mfg. |
NCT00937157: Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) |
|
|
| Completed | N/A | 12 | US | Copaxone, Glatiramer acetate | University at Buffalo, Teva Neuroscience, Inc. | Multiple Sclerosis | 07/10 | 04/11 | | |
NCT00587158: Oral Paricalcitol in Kidney Transplant Recipients |
|
|
| Completed | N/A | 100 | US | Paricalcitol, Brand name is Zemplar®, Corticosteroid Avoidance Immune Suppression Protocol, Standard Immune Suppression | Mayo Clinic, Abbott | Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, Secondary | 11/11 | 11/11 | | |
MSECP, NCT02296346: Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis |
|
|
| Terminated | N/A | 13 | US | SoluMedrol, Corticosteroids, Extracorporeal Photopheresis, ECP, Cellex machine, Therakos | University of Utah, Mallinckrodt | Secondary Progressive Multiple Sclerosis | 06/17 | 05/18 | | |
NCT01900093: Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS Relapses |
|
|
| Unknown status | N/A | 10 | US | Acthar Gel, Repository corticotrophin injection | Aaron Miller, Mallinckrodt | Multiple Sclerosis | 03/18 | 03/18 | | |
NCT02966379: Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor |
|
|
| Completed | N/A | 17 | Europe | cochlear implantation | Oticon Medical | Cochlear Implant | 10/18 | 10/18 | | |
NCT01265537: A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf |
|
|
| Completed | N/A | 30 | Canada | Tacrolimus, Advagraf | University of British Columbia, Astellas Pharma Canada, Inc. | Acute Graft Rejection, Diabetes | 02/19 | 10/19 | | |
